Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance

Conclusion Combined LP and S-ICD therapy appears feasible in all animal experiments (n = 2) and in one human subject. No interference in sensing and pacing during intrinsic and paced rhythm was noted in both animal and human subjects. However, induced arrhythmia testing was not performed in the patient. Defibrillation therapy did not seem to affect LP function. More data on safety and performance are needed.
Source: Europace - Category: Cardiology Authors: Tags: Basic Science Source Type: research